Exploring a new target for antibiotics against drug-resistant Acinetobacter baumannii
Determining the value of PBP 7/8 as an antimicrobial target for XDR-A. baumannnii
['FUNDING_OTHER'] · VA WESTERN NEW YORK HEALTHCARE SYSTEM · NIH-10946713
This study is looking at a special protein called PBP 7/8 to see if it can help create new antibiotics to fight Acinetobacter baumannii, a tough germ that can cause serious infections in people with weak immune systems.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VA WESTERN NEW YORK HEALTHCARE SYSTEM (nih funded) |
| Locations | 1 site (BUFFALO, UNITED STATES) |
| Trial ID | NIH-10946713 on ClinicalTrials.gov |
What this research studies
This research investigates the potential of a specific protein, PBP 7/8, as a target for developing new antibiotics against Acinetobacter baumannii, a bacterium known for causing severe infections, especially in patients with weakened immune systems. The study focuses on understanding how this protein is essential for the survival of the bacteria in various environments, including in the human body. By using advanced laboratory techniques and models, the research aims to identify new antimicrobial agents that can effectively combat infections caused by highly resistant strains of this pathogen.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from infections caused by Acinetobacter baumannii, particularly those with antibiotic-resistant strains.
Not a fit: Patients with infections caused by other types of bacteria that are not Acinetobacter baumannii may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that effectively treat infections caused by drug-resistant Acinetobacter baumannii.
How similar studies have performed: Other research has shown promise in targeting similar proteins in bacteria, indicating that this approach could be a viable strategy for developing new treatments.
Where this research is happening
BUFFALO, UNITED STATES
- VA WESTERN NEW YORK HEALTHCARE SYSTEM — BUFFALO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RUSSO, THOMAS A — VA WESTERN NEW YORK HEALTHCARE SYSTEM
- Study coordinator: RUSSO, THOMAS A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.